Piramal Pharma Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
26896.01 Cr.
|
P/BV
|
3.40
|
Book Value (Rs.)
|
59.53
|
52 Week High/Low (Rs.)
|
308/182
|
FV/ML
|
10/1
|
P/E(X)
|
295.39
|
Bookclosure
|
16/07/2025
|
EPS (Rs.)
|
0.69
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
No. of Equity Shares (in Lacs) | 13243.51 | 13229.48 | 11933.19 | 11859.14 | 9946.02 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 1324.35 | 1322.95 | 1193.32 | 1185.91 | 994.60 |
Total Share Capital | 1324.35 | 1322.95 | 1193.32 | 1185.91 | 994.60 |
| | | | | |
Reserves and Surplus | 6801.12 | 6588.42 | 5580.18 | 5510.69 | 4610.30 |
Total Reserves and Surplus | 6801.12 | 6588.42 | 5580.18 | 5510.69 | 4610.30 |
Money Received Against Share Warrants | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 |
Total Shareholders Funds | 8125.47 | 7911.37 | 6773.50 | 6696.60 | 5605.00 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 3214.07 | 2483.75 | 3383.54 | 2622.14 | 2339.16 |
Deferred Tax Liabilities [Net] | 248.35 | 229.18 | 219.31 | 192.01 | 222.49 |
Other Long Term Liabilities | 274.77 | 285.89 | 282.48 | 240.36 | 236.07 |
Long Term Provisions | 48.66 | 32.32 | 20.68 | 12.59 | 6.78 |
Total Non-Current Liabilities | 3785.85 | 3031.14 | 3906.01 | 3067.10 | 2804.50 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 1506.20 | 2075.11 | 2121.23 | 1401.14 | 360.52 |
Trade Payables | 1533.77 | 1538.37 | 1192.71 | 1026.35 | 917.94 |
Other Current Liabilities | 683.45 | 712.25 | 489.90 | 572.04 | 1180.04 |
Short Term Provisions | 42.85 | 43.57 | 39.21 | 33.81 | 31.78 |
Total Current Liabilities | 3766.27 | 4369.30 | 3843.05 | 3033.34 | 2490.28 |
| | | | | |
Total Capital And Liabilities | 15677.59 | 15311.81 | 14522.56 | 12797.04 | 10899.78 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 4534.37 | 4250.27 | 3588.52 | 3042.59 | 2766.74 |
Intangible Assets | 2450.85 | 2617.11 | 2772.57 | 2806.09 | 2482.28 |
Capital Work-In-Progress | 489.12 | 565.70 | 852.93 | 673.15 | 399.53 |
Intangible Assets Under Development | 487.78 | 550.10 | 565.65 | 499.19 | 227.12 |
Fixed Assets | 7962.12 | 7983.18 | 7779.67 | 7021.02 | 5875.67 |
Goodwill On Consolidation | 1148.21 | 1122.55 | 1107.51 | 1030.50 | 856.47 |
Non-Current Investments | 271.09 | 240.26 | 211.87 | 216.77 | 122.67 |
Deferred Tax Assets [Net] | 393.13 | 386.50 | 349.30 | 297.27 | 244.12 |
Other Non-Current Assets | 106.05 | 114.85 | 238.73 | 164.26 | 152.15 |
Total Non-Current Assets | 9880.60 | 9847.34 | 9687.08 | 8729.82 | 7251.08 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 19.56 | 144.69 | 427.11 | 50.40 | 0.00 |
Inventories | 2312.70 | 2175.88 | 1681.37 | 1388.80 | 1232.00 |
Trade Receivables | 2349.52 | 2134.43 | 1799.34 | 1785.28 | 1574.94 |
Cash And Cash Equivalents | 501.46 | 482.56 | 307.56 | 328.99 | 405.62 |
OtherCurrentAssets | 613.75 | 526.91 | 620.10 | 513.75 | 436.14 |
Total Current Assets | 5796.99 | 5464.47 | 4835.48 | 4067.22 | 3648.70 |
| | | | | |
Total Assets | 15677.59 | 15311.81 | 14522.56 | 12797.04 | 10899.78 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 925.66 | 288.52 | 305.78 | 365.47 | 203.55 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 177.67 | 177.67 | 177.67 | 177.67 | 0.00 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Unquoted Book Value | 46.50 | 34.94 | 41.76 | 36.95 | 13.00 |
| | | | | |
CURRENT INVESTMENTS | | | | | |
Current Investments Unquoted Book Value | 0.00 | 14.29 | 14.23 | 13.39 | 0.00 |